Standard immunohistochemistry efficiently screens for anaplastic lymphoma kinase rearrangements in differentiated thyroid cancer
- 1 February 2015
- journal article
- research article
- Published by Bioscientifica in Endocrine-Related Cancer
- Vol. 22 (1) , 55-63
Abstract
The anaplastic lymphoma kinase (ALK) gene is frequently rearranged in various types of cancer and is highly responsive to targeted therapeutics. We developed a system to detect rearrangement of ALK in a large group of Korean thyroid cancer patients. We screened 474 malignant or benign thyroid tumor cases to identify ALK fusions. Expression and translocation of the ALK gene were analyzed by immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), and digital multiplexed gene expression (DMGE) analysis in formalin-fixed paraffin-embedded tissues. Four cases of rearrangement of ALK were detected by IHC, and these cases were validated with FISH on 189 samples. On the other hand, DMGE analysis using Nanostring detected three out of four IHC-positive cases. Two rearrangements of ALK were striatin (STRN)–ALK fusions, which were identified by 5′ RACE analysis. Rearrangements of ALK were found exclusively in v-raf murine sarcoma viral oncogene homolog B (BRAF) WT papillary carcinomas. Given the wide availability and accuracy of IHC for detecting ectopic expression of ALK in the thyroid, we suggest that IHC-based screening can be a practical method for identifying patients with ALK rearrangements in differentiated thyroid cancer.Keywords
This publication has 31 references indexed in Scilit:
- A Comprehensive Comparative Analysis of the Histomorphological Features of ALK-Rearranged Lung Adenocarcinoma Based on Driver Oncogene Mutations: Frequent Expression of Epithelial-Mesenchymal Transition Markers than Other GenotypePLOS ONE, 2013
- 'Basket studies' will hold intricate data for cancer drug approvalsNature Medicine, 2013
- RET/PTC and PAX8/PPARγ chromosomal rearrangements in post‐Chernobyl thyroid cancer and their association with iodine‐131 radiation dose and other characteristicsCancer, 2013
- Identification of KIF5B-RET and GOPC-ROS1 Fusions in Lung Adenocarcinomas through a Comprehensive mRNA-Based Screen for Tyrosine Kinase FusionsClinical Cancer Research, 2012
- Molecular genetics and diagnosis of thyroid cancerNature Reviews Endocrinology, 2011
- A Novel, Highly Sensitive Antibody Allows for the Routine Detection ofALK-Rearranged Lung Adenocarcinomas by Standard ImmunohistochemistryClinical Cancer Research, 2010
- Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005Cancer, 2009
- Solid Variant of Papillary Thyroid CarcinomaAmerican Journal of Surgical Pathology, 2001
- Current Approaches to Primary Therapy for Papillary and Follicular Thyroid CancerThe Journal of Clinical Endocrinology & Metabolism, 2001
- Papillary and Follicular Thyroid CarcinomaNew England Journal of Medicine, 1998